The companies making and selling branded products need to understand how well their efforts are working to convince GPs to prescribe their brands. The graphic below shows a number of branded generics, however changes in the way they are reimbursed (VPAS) means that...
The companies making and selling branded generics do help to save the NHS money, though in a rather roundabout way. They could simply launch generics and compete with each other for market share. However, having their own brand names allows them to improve the quality...
In July 2022 a £13.65 concession price was granted to help pharmacists during a time of shortages and price rises. This product has seen its average market price, paid by pharmacists and dispensing doctors, declining gradually from over £60.00 in 2012 to less than...
The prices pharmacies and dispensing doctors pay for statins in the UK is very variable with prices for packs ranging from £0.01 to £14.64. This means that individual manufacturers and wholesalers adjust their prices to maximise sales and profits by trying to...
When the market price of a generic product declines to a point where manufacturers can no longer make a profit, they may decide to cancel or not commission the next batch of stock. Consequently, the price goes up as the available stock in the market declines. The low...
Since July 2013 the average price of Tranylcypromine Tabs 10mg 28 has risen from £101.69 to £364.52 in July 2022. The English Drug Tariff has also risen from £92.00 in July 2012 and is now £487.08 which means that pharmacies can make a profit of £122.56 on each pack...
